Ghislain M C Bonamy (G M C Bonamy)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 3

Top Topics

Tyrosine Kinase

Drug Administration

Combination Therapy

Top Venues

Scientific reports

ACS infectious diseases

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Stephanie A Moquin, Oliver Simon, Ratna Karuna, Suresh B Lakshminarayana, Fumiaki Yokokawa, Feng Wang, Chandra Saravanan, Jin Zhang, Craig W Day, Katherine Chan, Qing-Yin Wang, Siyan Lu, Hongping Dong, Kah Fei Wan, Siew Pheng Lim, Wei Liu, Cheah Chen Seh, Yen-Liang Chen, Haoying Xu, David T Barkan, Cyrille S Kounde, Wei Lin Sandra Sim, Gang Wang, Hui-Quan Yeo, Bin Zou, Wai Ling Chan, Mei Ding, Jae-Geun Song, Min Li, Colin Osborne, Francesca Blasco, Christopher Sarko, David Beer, Ghislain M C Bonamy, Vito G Sasseville, Pei-Yong Shi, Thierry Tidiane Diagana, Bryan K S Yeung, Feng Gu
NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models. Science translational medicine 13 (579) (2021)
Alexander T Chao, Boon Heng Lee, Kah Fei Wan, Jeremy Selva, Bin Zou, Peter Gedeck, David John Beer, Thierry T Diagana, Ghislain M C Bonamy, Ujjini H Manjunatha
Development of a Cytopathic Effect-Based Phenotypic Screening Assay against Cryptosporidium. ACS infectious diseases 4 (4) (2018)
L Dembele, X Ang, M Chavchich, Ghislain M C Bonamy, J J Selva, M Yi-Xiu Lim, C Bodenreider, B K S Yeung, Francois H Nosten, Bruce M Russell, M D Edstein, J Straimer, David A Fidock, T T Diagana, P Bifani
The Plasmodium PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites. Scientific reports 7 (1) (2017)